vs
雅培（ABT）与COMMUNITY HEALTH SYSTEMS INC（CYH）财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是COMMUNITY HEALTH SYSTEMS INC的3.7倍（$11.5B vs $3.1B）。雅培净利率更高（15.5% vs 3.5%，领先12.0%）。雅培同比增速更快（4.4% vs -4.8%）。雅培自由现金流更多（$2.6B vs $172.0M）。过去两年雅培的营收复合增速更高（7.2% vs -0.5%）
雅培是总部位于美国伊利诺伊州雅培园的跨国医疗健康企业，业务覆盖美国境外市场药品销售、诊断产品、营养产品及医疗器械等板块，在全球医疗健康领域拥有较高的行业知名度与广泛的市场覆盖。
社区卫生系统公司总部位于美国田纳西州富兰克林，是财富500强企业。按急症护理机构数量计算，该公司曾是美国最大的综合医院医疗服务提供商。2014年它旗下有约200家医院，到2021年机构数量缩减至约85家。
ABT vs CYH — 直观对比
营收规模更大
ABT
是对方的3.7倍
$3.1B
营收增速更快
ABT
高出9.3%
-4.8%
净利率更高
ABT
高出12.0%
3.5%
自由现金流更多
ABT
多$2.5B
$172.0M
两年增速更快
ABT
近两年复合增速
-0.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $11.5B | $3.1B |
| 净利润 | $1.8B | $110.0M |
| 毛利率 | 57.0% | 85.6% |
| 营业利润率 | 19.6% | 14.5% |
| 净利率 | 15.5% | 3.5% |
| 营收同比 | 4.4% | -4.8% |
| 净利润同比 | -80.8% | 254.9% |
| 每股收益（稀释后） | $1.01 | $0.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTCYH
| Q4 25 | $11.5B | $3.1B | ||
| Q3 25 | $11.4B | $3.1B | ||
| Q2 25 | $11.1B | $3.1B | ||
| Q1 25 | $10.4B | $3.2B | ||
| Q4 24 | $11.0B | $3.3B | ||
| Q3 24 | $10.6B | $3.1B | ||
| Q2 24 | $10.4B | $3.1B | ||
| Q1 24 | $10.0B | $3.1B |
净利润ABTCYH
| Q4 25 | $1.8B | $110.0M | ||
| Q3 25 | $1.6B | $130.0M | ||
| Q2 25 | $1.8B | $282.0M | ||
| Q1 25 | $1.3B | $-13.0M | ||
| Q4 24 | $9.2B | $-71.0M | ||
| Q3 24 | $1.6B | $-391.0M | ||
| Q2 24 | $1.3B | $-13.0M | ||
| Q1 24 | $1.2B | $-41.0M |
毛利率ABTCYH
| Q4 25 | 57.0% | 85.6% | ||
| Q3 25 | 55.4% | 85.1% | ||
| Q2 25 | 56.4% | 85.0% | ||
| Q1 25 | 56.9% | 84.5% | ||
| Q4 24 | 55.0% | 84.5% | ||
| Q3 24 | 55.8% | 84.8% | ||
| Q2 24 | 55.6% | 84.6% | ||
| Q1 24 | 55.2% | 84.5% |
营业利润率ABTCYH
| Q4 25 | 19.6% | 14.5% | ||
| Q3 25 | 18.1% | 7.9% | ||
| Q2 25 | 18.4% | 16.3% | ||
| Q1 25 | 16.3% | 9.0% | ||
| Q4 24 | 17.4% | 8.5% | ||
| Q3 24 | 17.5% | -6.6% | ||
| Q2 24 | 16.1% | 7.6% | ||
| Q1 24 | 13.9% | 7.4% |
净利率ABTCYH
| Q4 25 | 15.5% | 3.5% | ||
| Q3 25 | 14.5% | 4.2% | ||
| Q2 25 | 16.0% | 9.0% | ||
| Q1 25 | 12.8% | -0.4% | ||
| Q4 24 | 84.1% | -2.2% | ||
| Q3 24 | 15.5% | -12.7% | ||
| Q2 24 | 12.5% | -0.4% | ||
| Q1 24 | 12.3% | -1.3% |
每股收益（稀释后）ABTCYH
| Q4 25 | $1.01 | $0.82 | ||
| Q3 25 | $0.94 | $0.96 | ||
| Q2 25 | $1.01 | $2.09 | ||
| Q1 25 | $0.76 | $-0.10 | ||
| Q4 24 | $5.26 | $-0.53 | ||
| Q3 24 | $0.94 | $-2.95 | ||
| Q2 24 | $0.74 | $-0.10 | ||
| Q1 24 | $0.70 | $-0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.9B | $260.0M |
| 总债务越低越好 | $12.9B | $10.4B |
| 股东权益账面价值 | $52.1B | $-1.4B |
| 总资产 | $86.7B | $13.2B |
| 负债/权益比越低杠杆越低 | 0.25× | — |
8季度趋势，按日历期对齐
现金及短期投资ABTCYH
| Q4 25 | $8.9B | $260.0M | ||
| Q3 25 | $7.7B | $123.0M | ||
| Q2 25 | $7.3B | $456.0M | ||
| Q1 25 | $6.8B | $431.0M | ||
| Q4 24 | $8.0B | $37.0M | ||
| Q3 24 | $7.8B | $33.0M | ||
| Q2 24 | $7.2B | $39.0M | ||
| Q1 24 | $6.7B | $48.0M |
总债务ABTCYH
| Q4 25 | $12.9B | $10.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $14.1B | $11.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABTCYH
| Q4 25 | $52.1B | $-1.4B | ||
| Q3 25 | $51.0B | $-1.5B | ||
| Q2 25 | $50.6B | $-1.6B | ||
| Q1 25 | $48.8B | $-1.9B | ||
| Q4 24 | $47.7B | $-1.9B | ||
| Q3 24 | $39.8B | $-1.8B | ||
| Q2 24 | $39.3B | $-1.4B | ||
| Q1 24 | $38.8B | $-1.4B |
总资产ABTCYH
| Q4 25 | $86.7B | $13.2B | ||
| Q3 25 | $84.2B | $13.2B | ||
| Q2 25 | $84.0B | $13.6B | ||
| Q1 25 | $81.4B | $13.9B | ||
| Q4 24 | $81.4B | $14.1B | ||
| Q3 24 | $74.4B | $13.9B | ||
| Q2 24 | $73.0B | $14.4B | ||
| Q1 24 | $72.5B | $14.4B |
负债/权益比ABTCYH
| Q4 25 | 0.25× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.30× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.3B | $266.0M |
| 自由现金流经营现金流 - 资本支出 | $2.6B | $172.0M |
| 自由现金流率自由现金流/营收 | 22.9% | 5.5% |
| 资本支出强度资本支出/营收 | 6.0% | 3.0% |
| 现金转化率经营现金流/净利润 | 1.87× | 2.42× |
| 过去12个月自由现金流最近4个季度 | $7.4B | $208.0M |
8季度趋势，按日历期对齐
经营现金流ABTCYH
| Q4 25 | $3.3B | $266.0M | ||
| Q3 25 | $2.8B | $69.0M | ||
| Q2 25 | $2.0B | $88.0M | ||
| Q1 25 | $1.4B | $120.0M | ||
| Q4 24 | $2.9B | $216.0M | ||
| Q3 24 | $2.7B | $67.0M | ||
| Q2 24 | $2.0B | $101.0M | ||
| Q1 24 | $1.0B | $96.0M |
自由现金流ABTCYH
| Q4 25 | $2.6B | $172.0M | ||
| Q3 25 | $2.3B | $4.0M | ||
| Q2 25 | $1.5B | $-3.0M | ||
| Q1 25 | $933.0M | $35.0M | ||
| Q4 24 | $2.1B | $107.0M | ||
| Q3 24 | $2.1B | $-3.0M | ||
| Q2 24 | $1.4B | $13.0M | ||
| Q1 24 | $627.0M | $3.0M |
自由现金流率ABTCYH
| Q4 25 | 22.9% | 5.5% | ||
| Q3 25 | 20.2% | 0.1% | ||
| Q2 25 | 13.9% | -0.1% | ||
| Q1 25 | 9.0% | 1.1% | ||
| Q4 24 | 19.6% | 3.3% | ||
| Q3 24 | 20.2% | -0.1% | ||
| Q2 24 | 13.8% | 0.4% | ||
| Q1 24 | 6.3% | 0.1% |
资本支出强度ABTCYH
| Q4 25 | 6.0% | 3.0% | ||
| Q3 25 | 4.4% | 2.1% | ||
| Q2 25 | 4.5% | 2.9% | ||
| Q1 25 | 4.7% | 2.7% | ||
| Q4 24 | 6.6% | 3.3% | ||
| Q3 24 | 5.2% | 2.3% | ||
| Q2 24 | 5.1% | 2.8% | ||
| Q1 24 | 4.0% | 3.0% |
现金转化率ABTCYH
| Q4 25 | 1.87× | 2.42× | ||
| Q3 25 | 1.70× | 0.53× | ||
| Q2 25 | 1.15× | 0.31× | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 1.64× | — | ||
| Q2 24 | 1.51× | — | ||
| Q1 24 | 0.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABT
暂无分部数据
CYH
| Managed Care And Other Third Party Payors | $1.5B | 49% |
| Medicare Managed Care | $570.0M | 18% |
| Medicare | $512.0M | 16% |
| Medicaid | $464.0M | 15% |
| Self Pay Revenue | $34.0M | 1% |
